Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06027255 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Long COVID Immune Profiling

StatusActive, Not Recruiting
PhaseNot specified
Started2024-04-24
View on ClinicalTrials.gov ↗

Amendment history

2026-09-26
notable
Phase changed: not applicable → not specified
2026-07-14
notable
Recruiting→Active, Not Recruiting Study Status, Study Design, Contacts/Locations v7
Trial statusRecruiting→Active, Not Recruiting
Study sitesdetails revised at 1 of 1 site
2025-12-07
minor
Study Status v6
Primary completion date2025-10-31→2026-06-30
Completion date2026-10-31→2027-07-01
2025-06-20
minor
Study Status v5
Re-verified, no change to tracked fields
2024-06-10
notable
Not Yet Recruiting→Recruiting Study Status, Oversight, Contacts/Locations v4
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2024-04-01→confirmed 2024-04-24
Show 3 earlier versions
2024-03-11
minor
Study Status v3
Start date2024-01-30→2024-04-01
2024-01-10
minor
Study Status v2
Start date2023-12-01→2024-01-30
2023-11-04
minor
Study Status v1
Start date2023-10-01→2023-12-01
2023-09-06
minor
Original filing
Parasympathetic nervous system (PNS) is part of the body's autonomic nervous system(PNS) protects body against inflammation. Study shows that reduced PNS function activity is associated with persistent inflammation. Preliminary data from the studies shows, that post-COVID-19 POTS patients have reduced parasympathetic (PNS) function. Given that the PNS protects against inflammation, this clinical trial aims to prove that post-COVID-19 POTS is caused by reduced PNS activity, which in turn, contributes to persistent inflammation, orthostatic intolerance, and OI symptoms. The study will evaluate immune cell activation in post-COVID-19 POTS and patients with history of COVID-19 infection without sequelae and correlate this with the degree of decreased PNS activity.
Trial Details
NCT Number NCT06027255
Lead Sponsor Vanderbilt University Medical Center
Collaborators: American Heart Association
Conditions Long COVID, POTS - Postural Orthostatic Tachycardia Syndrome, Autonomic Dysfunction
Enrollment 150 participants
Start Date 2024-04-24
Primary Completion 2026-06-30 (estimated)
Study Completion 2027-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-09-25